ODAK partner PSR awarded Best Orphan Drug CRO 2013
- Published: Tuesday, 10 December 2013 10:30
PSR-Agility has been awarded 'Best Orphan Drug Contract Research Group' in the Rare & Orphan Advocacy and Research (ROAR) awards.
The ROAR Awards were announced during the 4th Annual World Orphan Drug Congress Europe, November 14-15, 2013, in Geneva, Switzerland. The inaugural 2013 awards are an opportunity to recognize and honour achievements by organizations and individuals from industry, patient and rare disease advocacy communities.
“Winning this award as the PSR-Agility Orphan Drug Development partnership is an important acknowledgement for our pioneering work in the rare disease community over the last 5 years,” says Roger Legtenberg, CEO of PSR Orphan Experts. “As a unique specialized service provider, our way of integrating innovative regulatory & clinical approaches and reaching crucial milestones for our clients has been the basis for winning this award. Our staff are all fully committed to the rare disease cause, taking part in fundraising events and other supportive activities.